ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
132 hedge funds and large institutions have $209M invested in Antares Pharma, Inc. in 2019 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
22% less call options, than puts
Call options by funds: $1.77M | Put options by funds: $2.26M
Holders
132
Holding in Top 10
3
Calls
$1.77M
Puts
$2.26M
Top Buyers
| 1 | +$3.98M | |
| 2 | +$3.14M | |
| 3 | +$2.55M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$1.72M |
| 5 |
Renaissance Technologies
New York
|
+$1.25M |
Top Sellers
| 1 | -$3.75M | |
| 2 | -$2.42M | |
| 3 | -$1.68M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.66M |
| 5 |
BlackRock
New York
|
-$981K |